EP 1395255 A4 20070912 - CDDO-COMPOUNDS AND COMBINATION THERAPIES THEREOF
Title (en)
CDDO-COMPOUNDS AND COMBINATION THERAPIES THEREOF
Title (de)
CDDO-VERBINDUNGEN UND KOMBINATIONSTHERAPIEN DAFÜR
Title (fr)
COMPOSES CDDO ET POLYTHERAPIES ASSOCIEES
Publication
Application
Priority
- US 0144541 W 20011128
- US 25367300 P 20001128
Abstract (en)
[origin: WO0247611A2] CDDO-compounds in combination with other chemotherapeutic agents induce and potentiate cytotoxicity and apoptosis in cancer cell. One class of chemotherapeutic agents include retinoids. Cancer therapies based on these combination therapies are provided, Also provided are methods to treat graft versus host diseases using the CDDO compounds.
IPC 1-7
IPC 8 full level
A61K 31/07 (2006.01); A61K 31/275 (2006.01); A61K 31/335 (2006.01); A61K 38/17 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61K 31/07 (2013.01); A61K 31/275 (2013.01); A61K 31/335 (2013.01); A61K 38/14 (2013.01); A61K 38/177 (2013.01); A61P 35/00 (2017.12)
Citation (search report)
- [A] CRIPE ET AL: "Adult acute leukemia", CURRENT PROBLEMS IN CANCER, MOSBY, ST LOUIS, MO, US, vol. 21, no. 1, January 1997 (1997-01-01), pages 1 - 64, XP005326940, ISSN: 0147-0272
- See references of WO 0247611A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0247611 A2 20020620; WO 0247611 A3 20031224; WO 0247611 A8 20030626; AU 4324602 A 20020624; CA 2430454 A1 20020620; EP 1395255 A2 20040310; EP 1395255 A4 20070912
DOCDB simple family (application)
US 0144541 W 20011128; AU 4324602 A 20011128; CA 2430454 A 20011128; EP 01989130 A 20011128